Association of a novel Fat-Muscle-BMI Index (FMBI) with NAFLD, liver fibrosis, and atherosclerotic cardiovascular disease risk: a cross-sectional study in 1,592 Chinese adults
Xiaokang Wu, Xinjiang Hou, Jiafeng Yin, Yue Li, Chaoliang Xiong, Hailong Liu, Hao Meng · 2026
Read Association of a novel Fat-Muscle-BMI Index (FMBI) with NAFLD, liver fibrosis, and atherosclerotic cardiovascular disease risk: a cross-sectional study in 1,592 Chinese adults by Xiaokang Wu, Xinjiang Hou, Jiafeng Yin, Yue Li, Chaoliang Xiong, Hailong Liu, Hao Meng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471350.txt.
Description
Wu and colleagues introduce a new body measure, the Fat-Muscle-BMI Index, built by multiplying the fat-to-muscle ratio by body mass index. Their 2026 cross-sectional study asked whether this combined score tracks fatty liver disease and heart risk in 1,592 Chinese adults aged 40 to 79.
Fatty liver prevalence climbed steadily across score quarters, from 46.0% in the lowest group to 72.4% in the highest group. Each one-point rise in the index came with 20% higher odds of fatty liver, and risk jumped once scores reached 10 or more. Among patients with fatty liver, top-quarter scores also carried 1.79 times the odds of liver scarring, and the index independently tracked cardiovascular risk. Smoking amplified the link, adding extra risk beyond either factor alone.
Catalog record
| CREATOR | Xiaokang Wu, Xinjiang Hou, Jiafeng Yin, Yue Li, Chaoliang Xiong, Hailong Liu, Hao Meng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |